6515--Justification and Approval Emergency COVID19 Duosol Dialysate

Page 2 of 2 Approved Justification 36A77620Q0280 EMERGENCY COVID19 Dialysate Order The supplies required are an immediate need to deal with the COVID-19 pandemic which was declared a National Emergency. This requirement is for cases of Duosol Bicarbonate Dialysate. Dialysate solution is required in the treatment of patients in severe renal distress due to COVID-19 and other co-morbid conditions. This notice serves as the synopsis of the contract action in accordance with Federal Acquisition Regulation (FAR) 5.102(a)(6), FAR 5.201, FAR 13.105, and FAR 13.106-1(b). The solicitation will be issued as an oral Request for Quotes (RFQ) for Duosol brand dialysate to the manufacturer and authorized dealer. Please find attached the approved brand name Justification and Approval (J&A) in accordance with FAR 5.102(a)(6) and FAR 13.106-1(b)(1)(ii). No quotes are being requested and will not be accepted for this requirement. Attachments: S02 ATTACHMENT Redacted Final JA for Dialysate for COVID19 CO 5.11.20